![background image](http://html.mh-extra.com/html/samsung/sgh-e720/sgh-e720_manual_1190616103.webp)
Health and Safety Information
198
• Support needed research into possible biological
effects of RF of the type emitted by wireless
phones;
• Design wireless phones in a way that minimizes
any RF exposure to the user that is not necessary
for device function; and
• Cooperate in providing users of wireless phones
with the best possible information on possible
effects of wireless phone use on human health
FDA belongs to an interagency working group of the
federal agencies that have responsibility for
different aspects of RF safety to ensure coordinated
efforts at the federal level. The following agencies
belong to this working group:
• National Institute for Occupational Safety and
Health
• Environmental Protection Agency Federal
Communications Commission
• Occupational Safety and Health Administration
• National Telecommunications and Information
Administration
• The National Institutes of Health participates in
some interagency working group activities, as
well.
FDA shares regulatory responsibilities for wireless
phones with the Federal Communications
Commission (FCC). All phones that are sold in the
United States must comply with FCC safety
guidelines that limit RF exposure. FCC relies on FDA
and other health agencies for safety questions
about wireless phones.
FCC also regulates the base stations that the
wireless phone networks rely upon. While these
Health and Safety Information
199
base stations operate at higher power than do the
wireless phones themselves, the RF exposures that
people get from these base stations are typically
thousands of times lower than those they can get
from wireless phones. Base stations are thus not
the primary subject of the safety questions
discussed in this document.
4. What is FDA doing to find out more about the
possible health effects of wireless phone RF?
FDA is working with the U.S. National Toxicology
Program and with groups of investigators around
the world to ensure that high priority animal studies
are conducted to address important questions
about the effects of exposure to radio frequency
energy (RF).
FDA has been a leading participant in the World
Health Organization International Electromagnetic
Fields (EMF) Project since its inception in 1996. An
influential result of this work has been the
development of a detailed agenda of research
needs that has driven the establishment of new
research programs around the world. The Project
has also helped develop a series of public
information documents on EMF issues.
FDA and the Cellular Telecommunications &
Internet Association (CTIA) have a formal
Cooperative Research and Development Agreement
(CRADA) to do research on wireless phone safety.
FDA provides the scientific oversight, obtaining
input from experts in government, industry, and
academic organizations. CTIA-funded research is
conducted through contracts to independent
investigators. The initial research will include both
laboratory studies and studies of wireless phone
users. The CRADA will also include a broad
assessment of additional research needs in the